Results

Total Results: 537 records

Showing results for "patient safety indicators".
Users also searched for: quality indicators

21. Screening for Thyroid Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/VQKnqHbLuuLGeo2qTt9KZU
    May 09, 2017 - the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety … therefore, for screening to be of benefit, studies are needed to determine which set of prognostic indicators … Safety of ultrasound-guided fine needle aspiration biopsy of neck lesions in patients taking antithrombotic … thyroid carcinoma: comparison of limited versus comprehensive lymph node dissection in a 2-year safety … Safety of thyroidectomy in residency: a review of 186 consecutive cases.

22. Screening for Genital Herpes Simplex: A Brief Update (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZzZp7_aoJn73k9z25w_-qr
    March 01, 2005 - , or to diagnose infection in a symptomatic patient when culture is not feasible or the clinical syndrome … There is limited evidence of acyclovir use and safety during pregnancy. … Safety profiles for all treatments were comparable. Good Table 2. … • Cesarean section and vaginal delivery were used for different patient subgroups in the cohort. … Patient? Analysis?

23. Archived: Final Evidence Review: Genital Herpes: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review55/genital-herpes-screening-2005
    March 15, 2005 - Safety profiles for all treatments were comparable. … Safety profiles were comparable between groups. … Safety profiles between groups were comparable. … The study did not examine safety of the neonate. … The study did not examine safety of the neonate.

24. Draft Recommendation: Depression and Suicide Risk in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/screening-depression-suicide-risk-adults
    September 20, 2022 - In an ESR of older adults, 14 included trials did not report safety data. 1 Twenty-one ESRs (~522 RCTs … screened, referred, and treated as well as patient health outcomes. … Key Substance Use and Mental Health Indicators in the United States: Results From the 2018 National Survey … Prevalence of Selected Maternal and Child Health Indicators for All PRAMS Sites, Pregnancy Risk Assessment … https://www.cdc.gov/prams/prams-data/mch-indicators/states/pdf/2019/All-Sites_PRAMS_Prevalence-of-Selected-Indicators

25. Evidence Summary: Hepatitis B Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hepatitis-b-virus-infection-screening
    December 15, 2020 - Data Abstraction and Quality Rating One investigator abstracted details about the study design, patient … Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: a randomized controlled … Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis … Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 … the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety

26. Archived: Evidence Summary: Bacterial Vaginosis in Pregnancy to Prevent Preterm Delivery: Screening, 2001 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/bacterial-vaginosis-pregnancy-prevent-preterm-delivery-screening-2001
    January 01, 2001 - Comparisons of patient populations, treatment regimens, and study designs did not explain the heterogeneity … predictive value, but they are subject to interobserver variation. 25 Recently, test kits with simple indicators … Patients with symptomatic BV were not explicitly excluded. … It explicitly excluded symptomatic patients. … Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 1995; 172:525–9. 34.

27. Primary Care–Relevant Interventions to Prevent Opioid Use Disorder: Current Research and Evidence Gaps (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/prevention-of-opioid-user-disorder-ehc-tech-brief.pdf
    May 14, 2021 - Furthermore, this body of evidence is lacking data on patient health outcomes, including patient safety … In June 2020, the CDC sought comments from patients, patient family members/caregivers, and healthcare … Importantly, we are lacking data on patient safety, aberrant behavior, opioid misuse and abuse, and … Key Substance Use and Mental Health Indicators in the United States: Results From the 2018 National … US RCT Oral surgery practice Oral surgery patients (N=58) Patient education handout

28. Evidence Summary: Depression and Suicide Risk in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/screening-depression-suicide-risk-adults
    June 20, 2023 - Key Substance Use and Mental Health Indicators in the United States: Results From the 2019 National Survey … Item-based analysis of the effects of duloxetine in depression: a patient-level post hoc study. … Psychological treatment of depression in people aged 65 years and over: a systematic review of efficacy, safety … the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety … groups A separate review among older adults reported that none of the 14 included trials reported safety

29. Evidence Summary: Hypertensive Disorders of Pregnancy: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hypertensive-disorders-pregnancy-screening
    September 19, 2023 - epidemiologic evidence tends to be inferred based on physiology (ie, pregnancy) rather than reported by patients … changes to screening programs could not be separated from the effects of concurrent interventions (eg, patient … visits compared with the usual number (3 studies, n = 5203), and urine screening tests conducted for patients … the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety … compared with routine screening control Insufficient US populations obtaining prenatal care in safety-net

30. Archived: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/latent-tuberculosis-infection-screening-september-2016
    September 06, 2016 - initiating anti-tumor necrosis factor treatment, patients receiving dialysis, patients preparing for … Occupational Safety and Health Administration. … Washington, DC: Occupational Safety and Health Administration; 2015. Directive No. … Occupational Safety and Health Administration, U.S. Department of Labor. … http://www.aafp.org/patient-care/browse/type.tag-clinical-practice-guidelines.html . 2016.

31. Evidence Summary: Celiac Disease: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/other-supporting-document/celiac-disease-screening
    March 28, 2017 - Celiac disease may also be silent (the patient meets celiac disease diagnostic criteria but does not … Extraction and Quality Assessment One investigator extracted details about each article’s study design, patient … A phase 2a, double-blind, placebo controlled study of the efficacy, safety and tolerability of 6-weeks … IIb, randomized, double-blind, placebo controlled, dose ranging, multicenter study to determine the safety … the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety

32. Archived: Evidence Summary: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication, 2002 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/aspirin-use-prevent-cardiovascular-disease-colorectal-cancer-preventive-medication-2002
    January 15, 2002 - Aspirin reduced the incidence of MIs in men (2.9/1,000 patient-years in the aspirin group vs 5/1,000 … patient-years in controls; RR, 0.58; 95 percent CI, 0.41 to 0.81). … the aspirin group vs 2.1/1,000 patient years in controls; RR, 0.81; 95 percent CI, 0.49 to 1.31). … Efficacy and safety of different aspirin dosages on vascular disease in high-risk patients: A metaregression … Aspirin for primary prevention of coronary heart disease: Safety and absolute benefit related to coronary

33. Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/xUc_vXf7323faUQY7SePhT
    January 01, 2002 - Effectiveness of Aspirin Chemoprevention in Patient Subgroups The majority of participants in the 5 … patient-years in controls; RR, 0.58; 95% CI, 0.41 to 0.81). … in the aspirin group vs 2.1/1,000 patient years in controls; RR, 0.81; 95% CI, 0.49 to 1.31). … Efficacy and safety of different aspirin dosages on vascular disease in high-risk patients: a metaregression … Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary

34. Archived: High Blood Cholesterol and Other Lipid Abnormalities: Screening, 1996 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/high-cholesterol-other-lipid-abnormalities-screening-1996
    January 01, 1996 - Laboratory assays are subject to random errors, due to variation in sample collection, handling, and reagents … and Helsinki studies 91 A single trial (the WHO clofibrate study) accounts for nearly half of all patient-years … This assessment should take into account the age of the patient (higher risk in men over 45 and women … Safety of treatment, changes in risk factors, and incidence of coronary heart disease. … The Helsinki Heart Study: an 8. 5 year safety and mortality follow-up.

35. Evidence Summary: Prevention of Acquisition of HIV: Preexposure Prophylaxis | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
    August 22, 2023 - Data Abstraction and Quality Rating One investigator abstracted details about the study design, patient … What is the diagnostic accuracy of provider or patient risk assessment tools in identifying persons at … Otherwise, risk prediction instruments were based on information obtained from patient interviews, health … All adverse events were grade 1 except in 1 patient with grade 2 symptoms. … AIDS Patient Care STDS . 2021;35(1):5-8. doi:10.1089/apc.2020.0231 58.

36. Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: Updated Evidence Report and Systematic Review for the US Preventive Service Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/TkWNoq6KQb3SoZ54gscLCQ
    July 25, 2016 - Data Abstraction and Quality Rating One investigator abstracted details about the study design, patient … the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety … Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: a randomized controlled … Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis … Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18

37. JAMA (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/4_pXjq7Egjwb_vjZZT-NGB
    May 01, 2021 - 1091. doi:10.1001/jama.2023.4934 Editorial page 1040 Multimedia Related article page 1074 and JAMA Patient … epidemiologic evidence tends to be inferred based on physiology (ie, pregnancy) rather than reported by patients … to screening pro- grams could not be separated from the effects of concurrent inter- ventions (eg, patient … visits compared with the usual number (3 studies, n = 5203), and urine screening tests conducted for patients … the key questions that the review will address to allow the USPSTF to evaluate the effectiveness and safety

38. Screening for Child and Adolescent Depression in Primary Care Settings: A Systematic Evidence Review (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/R33bUm6oyjhWnbw96pJHwE
    April 01, 2009 - Depression treatment during out- patient visits by U.S. children and adolescents. … Committee on Safety of Medicines. … Review of the efficacy and safety of antidepressants in youth depression. … Treatment for Adoles- cents With Depression Study (TADS): safety results. … The Treatment for Adoles- cents With Depression Study (TADS): long-term effectiveness and safety outcomes

39. Evidence Summary: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
    June 11, 2019 - there were no HIV infections or results were combined with daily PrEP. 21 , 39 In all trials, all patients … What is the diagnostic accuracy of provider or patient risk assessment tools in identifying individuals … The number of participants with seroconversion in each study was small (1 to 4 patients per study). … Duration of Follow-up Interventions b HIV Risk Group; Risk-Based Inclusion Criteria Patient … c Sample of patient who reported that they were taking PrEP.

40. Archived: Evidence Summary: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis-june-2019
    June 11, 2019 - there were no HIV infections or results were combined with daily PrEP. 21 , 39 In all trials, all patients … What is the diagnostic accuracy of provider or patient risk assessment tools in identifying individuals … The number of participants with seroconversion in each study was small (1 to 4 patients per study). … Duration of Follow-up Interventions b HIV Risk Group; Risk-Based Inclusion Criteria Patient … c Sample of patient who reported that they were taking PrEP.